QGEN vs BIO-B

Comparison between Qiagen NV (QGEN, Company) and Bio-Rad Laboratories Inc - Class B (BIO-B, Company).

Both QGEN and BIO-B are from the Healthcare sector.

5-Year PerformanceQGEN has outperformed BIO-B, delivering a return of -6.0% compared to -14.8%

QGEN vs BIO-B - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	QGEN(COMPANY)	BIO-B(COMPANY)
Market Cap	$7.24B	$7.21B
Max Drawdown	92.14%	72.48%
Sharpe Ratio	-0.56	0.26
5Y Beta	0.52	-0.11
Industry	Diagnostics & Research	Medical Devices
P/E Ratio	17.04	-14.62
Forward P/E	11.04	30.21
PEG Ratio	0.04	1.21
Dividend Yield	0.77%	N/A
5Y EPS CAGR	3.15%	N/A
Debt to Equity	43.79%	11.72%
Free Cash Flow Yield	6.26%	4.95%
P/S Ratio	3.45	2.76
P/B Ratio	2.12	1.04

Market Cap

Winner

QGEN

$7.24B

BIO-B

$7.21B

Max Drawdown

QGEN

92.14%

Winner

BIO-B

72.48%

Sharpe Ratio

QGEN

-0.56

Winner

BIO-B

0.26

5Y Beta

QGEN

0.52

Winner

BIO-B

-0.11

Industry

QGEN

Diagnostics & Research

BIO-B

Medical Devices

P/E Ratio

QGEN

17.04

Winner

BIO-B

-14.62

Forward P/E

Winner

QGEN

11.04

BIO-B

30.21

PEG Ratio

Winner

QGEN

0.04

BIO-B

1.21

Dividend Yield

QGEN

0.77%

BIO-B

N/A

5Y EPS CAGR

QGEN

3.15%

BIO-B

N/A

Debt to Equity

QGEN

43.79%

Winner

BIO-B

11.72%

Free Cash Flow Yield

Winner

QGEN

6.26%

BIO-B

4.95%

P/S Ratio

QGEN

3.45

Winner

BIO-B

2.76

P/B Ratio

QGEN

2.12

Winner

BIO-B

1.04

QGEN vs BIO-B - Historical Returns

Returns include dividend reinvestment.

Period	QGEN	BIO-B
1 month	-12.01%	-10.69%
3 months	-25.88%	-0.54%
6 months	-25.30%	-13.93%
1 year	-16.89%	+6.94%
5 years(CAGR)	-5.97%	-14.82%
10 years(CAGR)	+5.03%	+6.40%
Max(CAGR)	+3.72%	+12.53%

QGEN

-12.01%

Winner

BIO-B

-10.69%

QGEN

-25.88%

Winner

BIO-B

-0.54%

QGEN

-25.30%

Winner

BIO-B

-13.93%

QGEN

-16.89%

Winner

BIO-B

+6.94%

5Y(CAGR)

Winner

QGEN

-5.97%

BIO-B

-14.82%

10Y(CAGR)

QGEN

+5.03%

Winner

BIO-B

+6.40%

Max(CAGR)

QGEN

+3.72%

Winner

BIO-B

+12.53%

QGEN vs BIO-B - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	QGEN	BIO-B
2026	-22.57%	-13.93%
2025	+1.53%	-4.58%
2024	+1.85%	+1.54%
2023	-13.02%	-20.76%
2022	-8.16%	-44.94%
2021	+4.26%	+25.91%
2020	+55.76%	+54.89%
2019	-0.97%	+60.70%
2018	+9.85%	-3.46%
2017	+9.49%	+30.08%
2016	+4.90%	+33.03%
2015	+18.31%	+14.67%
2014	-0.30%	-2.37%
2013	+26.78%	+15.80%
2012	+28.18%	+6.31%
2011	-30.43%	-9.98%
2010	-13.72%	+6.86%
2009	+30.51%	+31.80%
2008	-19.30%	-30.83%
2007	+34.59%	+28.86%
2006	+25.66%	+28.31%
2005	+6.53%	+14.04%
2004	-11.12%	-2.64%
2003	+118.25%	+36.47%
2002	-72.71%	+32.81%
2001	-46.97%	+103.17%
2000	+68.73%	+36.25%
1999	+41.78%	-0.56%

QGEN vs BIO-B Drawdown Comparison

The maximum drawdown for QGEN was -92.14%, occurring on Oct 2, 2002. This drawdown has not yet recovered.

The maximum drawdown for BIO-B was -72.48%, occurring on Apr 9, 2025. This drawdown has not yet recovered.

The current QGEN drawdown is -38.87%. The current BIO-B drawdown is -67.33%.

Rank	QGEN	BIO-B
#1	-92.14% Jul 17, 2000 - Oct 2, 2002	-72.48% Sep 10, 2021 - Apr 9, 2025
#2	-47.30% Mar 10, 2000 - Jul 17, 2000	-50.14% Aug 11, 2008 - Apr 20, 2010
#3	-23.35% Jan 24, 2000 - Feb 3, 2000	-35.34% Mar 1, 2000 - Nov 29, 2000
#4	-17.37% Dec 13, 1999 - Jan 10, 2000	-34.33% Jun 19, 2002 - May 20, 2003
#5	-10.78% Feb 25, 2000 - Mar 6, 2000	-31.86% Sep 4, 2018 - Aug 2, 2019
#6	-8.82% Nov 11, 1999 - Dec 1, 1999	-31.00% May 3, 2011 - Jan 9, 2014
#7	-8.59% Feb 8, 2000 - Feb 18, 2000	-27.68% Nov 8, 2007 - Aug 11, 2008
#8	-5.12% Jan 10, 2000 - Jan 14, 2000	-25.78% May 3, 2010 - Mar 7, 2011
#9	-3.14% Dec 8, 1999 - Dec 13, 1999	-23.33% Dec 26, 2003 - Aug 2, 2005
#10	-2.02% Nov 4, 1999 - Nov 10, 1999	-22.65% Feb 1, 2007 - Sep 27, 2007
#11	-1.67% Mar 7, 2000 - Mar 9, 2000	-20.71% May 17, 2002 - Jun 17, 2002
#12	-0.47% Nov 1, 1999 - Nov 3, 1999	-19.75% Feb 18, 2020 - Apr 14, 2020
#13	N/A	-19.59% Jun 6, 2003 - Dec 26, 2003
#14	N/A	-18.74% Feb 20, 2014 - Mar 12, 2015
#15	N/A	-18.70% Nov 6, 2020 - Feb 12, 2021